Awaiting development: Guidance and quality standards
Showing 1 to 2 of 2
| Title | Type |
|---|---|
| Port Delivery platform with ranibizumab for treating wet age-related macular degeneration [ID3983] | Technology appraisal guidance |
| Ranibizumab port delivery system for treating diabetic macular oedema [ID6137] | Technology appraisal guidance |